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Obesity is currently considered a major source of morbidity, with dramatic complica-
tions on health status and life expectancy. Several studies demonstrated the positive
effects of Brassicaceae vegetables on obesity and related diseases, partially attribut-
ing these beneficial properties to glucosinolates and their derivatives isothiocyanates.
Recently, isothiocyanates have been described as a hydrogen sulfide (H2S)-releasing
moiety, suggesting that H2S may be at least in part responsible for the beneficial
effects of Brassicaceae. In this work, the metabolic effects of an extract obtained
from Eruca sativa Mill. seeds (E.S., Brassicaceae), containing high levels of glucoerucin,
were evaluated in an experimental model of obesity. Male balb/c mice were fed for
10 weeks with standard (Std) diet or high fat (HF) diet supplemented with
E.S. E.S. significantly contained the body weight gain in this obesity model, improving
also glucose homeostasis. Interestingly, lower values of white adipose tissue mass
and a significant reduction of adipocytes size were also observed. Moreover,
E.S. enhanced the adipocytes metabolism, improving the citrate synthase activity and
reduced triglyceride levels in mice fed with HF diet. Taken together, these results
suggest that E.S. is endowed with an interesting translational and nutraceutical value
in the prevention of metabolic disorders, suggesting that H2S could be a key player.
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1 | INTRODUCTION
Obesity is a main health issue among children and adults worldwide.
According to the World Health Organization (WHO), 39% of the
global population is overweight and 13% is affected by obesity (N.R.F.
C. (NCD-RisC), 2016; Kopelman, 2000; Kopelman, 2007). Obesity is
currently considered a major source of morbidity, with dramatic com-
plications also on health status and life expectancy (Cheung, Cunning-
ham, Narayan, & Kramer, 2016; Younossi et al., 2016). Several studies
have demonstrated a strong correlation between obesity and
increased risk of cardiovascular disorders onset, especially heart fail-
ure, hypertension and coronary heart disease. Moreover, an increased
incidence of type II diabetes in obese people has been observed
(Garg, Maurer, Reed, & Selagamsetty, 2014; Kachur, Lavie, de
Schutter, Milani, & Ventura, 2017; Michalakis, Mintziori, Kaprara,
Tarlatzis, & Goulis, 2013).
Obesity is a condition characterized by an excessive body weight
for a given height; in particular in humans, it has been defined by the
National Institutes of Health (the NIH) as a body mass index (BMI)
greater than 30. However, obesity is a more complex condition typi-
cally accompanied by systemic oxidative stress and low-grade inflam-
mation (Hotamisligil, Shargill, & Spiegelman, 1993). Moreover, health
risks are related not only with the total amount of fat, but also with
the sites of fat deposition and the type of the adipose tissue. Indeed,
two different types of adipose tissue have been described: the white
adipose tissue (WAT), localized at subcutaneous and visceral level,
accumulates large amounts of triglycerides during periods of energy
excess and mobilizes them under conditions of energy deficiency
(Tchernof & Després, 2013), and the brown adipose tissue (BAT)
highly vascularized and mitochondria-rich. BAT represents a small per-
centage of body fat and its main function is the thermogenesis. Grow-
ing evidence suggests that the activation of BAT may be responsible
for beneficial effects on obesity, insulin resistance and hyperlipidemia
(Harms & Seale, 2013).
Eruca sativa Mill. (E.S.) is an edible vegetable from Brassicaceae
botanic family, commonly known as rocket salad. Very recently, Mar-
telli and colleagues described the vasoactive and antihypertensive
properties of erucin, the characteristic isothiocyanate derived from
E.S., and these health promoting effects have been mainly attributed
to the hydrogen sulfide (H2S)-releasing properties of erucin (Martelli,
Citi, Testai, Brogi, & Calderone, 2020a). Moreover, glucoerucin, the
glucosinolate typical of E.S., exhibits H2S-mediated anti-nociceptive
effects in diabetic rats (Lucarini et al., 2019). In addition, E.S. extracts
show inhibition of platelet activation, aggregation and release of
inflammatory mediators, through the inhibition of the pro-
inflammatory transcription factor NF-κB (Fuentes, Alarcón, Fuentes,
Carrasco, & Palomo, 2014).
In this work, we investigate the metabolic effects of an extract
obtained from E.S. seed, containing high levels of glucoerucin (precur-
sor of erucin) in mice fed with a HF diet.
2 | MATERIALS AND METHODS
2.1 | Plant material
Seeds of E.S. var. NEMAT were collected at CREA-CI (Lazzeri
et al., 2013; Lazzeri, Errani, Leoni, & Venturi, 2004) and extract was
obtained following procedures as reported in supplementary mate-
rials. According to literature (Franco et al., 2016) the amount of GSLs
were estimated through HPLC-UV analysis and using purified sinigrin
as an internal standard.
2.2 | In vivo chronic treatment
All the procedures were performed according to European (EEC
Directive 2010/63) and Italian (D.L. March 4, 2014 n. 26) legislation
(protocol number 12/2019-PR, 10/01/2019). Animals were housed in
cages with food and water ad libitum, and they were exposed to
12 hr:12 hr light:dark cycles.
12-Week-old Balb/c male mice (20–25 g, Envigo, Italy) were ran-
domly assigned into four groups (10 animals per group) and were
treated for 10 weeks. One group was fed with pulverized standard
diet (Std group, Envigo, Italy; Table 1); another one was fed with pul-
verized high-fat (HF) diet (HF group, 45% Kcal derived from fat, SAFE,
France; Table 1); the third one was fed with Std diet enriched with
the E.S. seed extract 0.75% w/w (Std + E.S. group); the last group was
fed with HF diet enriched with the E.S. seed extract 0.75% w/w (HF
+ E.S. group). This percentage of E.S. extract (0.75% w/w) ensured a
daily intake of 15 μmol of glucosinolates for each mouse
(corresponding to 577 μmol kg−1), and this dosage has been selected
on the basis of previous papers of others (Nagata et al., 2017).
Mice were weighed twice a week and food intake was daily moni-
tored over a period of 10 weeks. At the end of the treatment, mice
were sacrificed with an overdose of an aqueous solution of urethane
(20% w/v, Sigma-Aldrich, USA), and BMI was measured. Then, the
blood was collected and the WAT and the liver were explanted,
weighed and stored at −80C for functional and histological analysis.
2.3 | Measurement of cardiometabolic parameters
Before anesthesia, fasting blood sugar levels were measured by col-
lecting blood from the tail tip of each animal. Glucose concentration
was determined using Glucocard™ blood glucose meter (Menarini,
Italy). Then, mice were anaesthetized with an intraperitoneal injection
of urethane 20% w/v and intracardiac blood was collected in tubes
containing the anticoagulant EDTA (BD Vacutainer, BD Diagnostics
Preanalytical Systems, Canada) to measure glycated haemoglobin
(HbA1c) and lipids (total cholesterol, LDL and triglycerides) levels with
Cobas b 101 instrument (Roche Diagnostics, Switzerland).
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2.4 | Evaluation of citrate synthase activity
in WAT
WAT was finely cut and homogenized with an Ultra-Turrax homoge-
nizer (IKA-Werke GmbH & Co., Germany) in an ice-cold isolation
buffer (composition: sucrose 250 mM, Tris 5 mM, EGTA 1 mM, Triton
X-100 0.02%, pH 7.4); three homogenization cycles were performed
on ice. The suspension was centrifuged at 12000×g for 15 min at 4C
(Speed Master 14 R centrifuge; Euroclone, Italy) and the supernatant
was used for the assay. Protein concentration was measured spectro-
photometrically by Bradford's protein assay (Sigma-Aldrich, USA).
Then, samples were diluted in Tris-buffer 100 mM (pH 8.2) containing
5,50-dithiobis-(2-nitrobenzoic) acid (DTNB, 100 μM) and acetyl-
coenzyme A (100 μM). The assay was performed in 96-well plates and
the reaction was initiated by the addiction of oxalacetate (500 μM).
Absorption was measured spectrophotometrically at 30C and
412 nm every 30 s for 15 min using a microplate reader (EnSpire;
PerkinElmer, USA). All reagents were purchased from Sigma-Aldrich.
Citrate synthase (CS) activity was determined by using a calibration
curve obtained with known concentrations of the enzyme.
2.5 | Histological evaluation of adipocytes size
Six WAT samples per group were thawed in 4% paraformaldehyde.
After routine processing for paraffin embedding, sections (4 μM) were
stained with Hematoxylin and Eosin (H&E) for morphological examina-
tion. Then, they were analyzed by visual examination to identify any
diet-associated changes. Representative images were acquired by the
Nis-elements Br software associated to a Ni-E microscope (Nikon
Instruments SPA, Japan).
2.6 | Statistical analysis
All data were expressed as mean ± standard error (SEM). One-way
ANOVA followed by Bonferroni's post hoc test has been selected for
analyzing differences among experimental groups. p < .05 was considered
representative of significant differences (software: GraphPad Prism 6.0).
3 | RESULTS
3.1 | Characterization of the extracts
The total glucosinolate content of E.S. defatted seed meal was
101 μmoL g−1. 35 g of brown powder were obtained enriched with
23 ± 2 μmol g−1 glucoraphanin and 498 ± 2 μmol g−1 glucoerucin, with
an overall yield of extraction of 45% referring to glucosinolate content
in defatted meal. No traces of residual E.S. seed oil was detected in
final extract after standard automated continuous extraction by using
a E-816 ECE (Economic Continuous Extraction) extraction unit
(BÜCHI Labortechnik AG, Switzerland), and hexane as solvent.
3.2 | Effects of Eruca sativa Mill. seed extract on
HF diet-induced body weight gain
The baseline weight of mice was 26.2 ± 0.5 g. During the 10 weeks of
treatment, mice fed with standard diet (Std group) showed a physio-
logical increase in the body weight (13.2 ± 2.2% at the last day of
treatment). Interestingly, mice daily fed with a standard diet plus
E.S. seed extract (Std + E.S. group) showed body weight increase sig-
nificantly lowered (9.0 ± 1.1% on the last day of treatment). Mice fed
with the high-fat diet (HF group) showed a body weight increase sig-
nificantly higher if compared with Std group (27.7 ± 2.1% on the last
day of treatment). Conversely, daily oral treatment with E.S. seed
extract (HF + E.S. group) significantly contained HF-induced body
weight gain in mice fed with high-fat diet, since the percentage value
of body weight increase on the last day of treatment was 20.7 ± 1.4%
in this experimental group (Figure 1).
Accordingly, daily consumption of E.S. contained also HF diet-
induced BMI increase (Figure 2). Indeed, as expected, HF fed mice
showed a significantly higher BMI value, if compared with STD diet;
conversely, the supplementation with E.S. contributed to contain this
parameter, that it was superimposable to STD diet.
3.3 | Effects of Eruca sativa Mill. Seed extract on
the WAT
According to the composition of the HF diet, the weight of WAT of
mice belonging to HF group was significantly higher than that of mice
fed with Std diet (Figure 3a). Interestingly, daily treatment with
E.S. seed extract for 10 weeks clearly, albeit not significantly, reduced
adipose tissue weight of animal fed with HF diet (Figure 3a). Daily
consumption of HF diet for 10 weeks deeply modified the metabolic
activity of adipose tissue. Indeed, CS activity, which is an index of tis-
sue metabolic condition, was significantly lower in HF group com-
pared to Std group (0.480 ± 0.03 nmol min−1 mg−1 proteins vs 0.996
± 0.21 nmol min−1 mg−1 proteins). In contrast, CS activity was almost
completely recovered (0.919 ± 0.11 nmol min−1 mg−1 proteins) in HF
+ E.S. group (Figure 3b). No significant changes have been observed
between Std and Std + E.S. groups.

















Std 14.3 4.0 48.0 33.7 20.0 13.0 67.0 2.9
HF 20.3 24.0 43.3 12.4 17.3 45.9 36.8 4.7
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Furthermore, the histological analysis of adipose tissue showed a
significant increase in size of adipocytes of HF group mice, compared
to the Std group; interestingly, the dietary intake of E.S. significantly
reduced the adipocyte size of animals fed with a HF diet (Figure 4a–d).
3.4 | Effects of Eruca sativa Mill. seed extract on
lipid profile
HF-diet fed mice showed higher levels of total cholesterol, LDL and
triglycerides if compared with Std group. The supplementation of the
standard diet with E.S. seed extract (Std + E.S. group) did not affect
total cholesterol and LDL values, while a reduction in the levels of tri-
glycerides was observed. Conversely, in the HF group the supplemen-
tation with E.S. seed extract contributed to reduce all the parameters,
particularly the triglyceride levels (Table 2).
3.5 | Hypoglycemic effects of Eruca sativa Mill.
seed extract
After 10 weeks of treatment, both fasting blood glucose and HbA1c
levels were measured. No significant differences have been observed
in blood glucose levels between Std group and HF group, suggesting
that such HF diet did not induce evident hyperglycemic conditions
during the 10 weeks of treatment. Nevertheless, an increasing trend
in levels of HbA1c was measured in the HF group compared to the
Std group, indicating that HF may have actually acted as a diabeto-
genic factor. Notably, dietary intake of E.S. strikingly and significantly
reduced both blood glucose and HbA1c levels in mice fed with a HF
diet (Figures 5a,b).
4 | DISCUSSION
Obesity is a condition that impairs quality of life and is a main risk fac-
tor for several chronic diseases, including type II diabetes and cardio-
vascular diseases (Williams, Mesidor, Winters, Dubbert, &
Wyatt, 2015; N.R.F.C. (NCD-RisC), 2016; González-Muniesa
et al., 2017); therefore, the identification of effective nutraceuticals is
a goal in prevention and treatment of obesity. In this study, the anti-
obesity and hypoglycemic effects of dietary supplementation with
E.S. seed extract on HF diet-induced obesity has been evaluated in
mice. HF diet is considered a reliable experimental model of obesity;
indeed, it promotes body weight gain, hyperlipidemia and an alter-
ation of glucose homeostasis in rodents (Pinheiro-Castro, Silva,
Novaes, & Ong, 2019).
E.S. belongs to the Brassicaceae family. It contains numerous edi-
ble vegetables commonly used as food, including broccoli, cabbage,
cauliflower, raphanus and brussels sprouts. To date, several preclinical
and clinical evidence shows the cardiovascular beneficial effects of
these edible plants (Raiola et al., 2017).
The main finding of this work is the capability of E.S. seed extract
to reduce the body weight gain in an experimental model of obesity,
improving also glucose homeostasis. Importantly, the reduction of
body weight gain was not due to an anorexigen effect, since both HF
and HF + E.S. diets, although associated with a lower food intake
compared to Std group, did not significantly affect daily caloric intake
of mice (data not shown).
Interestingly, beside body weight containment, lower values of
BMI and WAT mass were observed; such a beneficial effect was con-
firmed from histo-morphological evaluation, in which a significant
reduction of adipocytes size has been highlighted. Indeed, in mice fed
with a HF diet WAT expands by storing triglycerides in the central
lipid droplet; therefore, the reduction of triglyceride levels, observed
F IGURE 2 Effects of Eruca sativa Mill. on BMI. Histograms show
the effects of Eruca sativa Mill. (E.S.) on the body mass index (BMI) of
mice fed with standard diet (Std), standard diet plus Eruca sativa Mill.
(Std + E.S.), high-fat diet (HF) and high-fat diet plus Eruca sativa Mill.
(HF + E.S.) for 10 weeks. Data are expressed as mean ± SEM. “*”
indicates significant difference vs Std group (**p < .01) while “§”
indicates significant difference vs HF group (§p < .05). Number of
animals for each group is n = 10
F IGURE 1 Effects of Eruca sativa Mill. (E.S.) seed extract on high-
fat diet-induced body weight increase. Graph shows the weight
increase (%) of mice fed with standard diet (Std), standard diet plus
Eruca sativa Mill. (Std + E.S.), high-fat diet (HF) or high-fat diet plus
Eruca sativa Mill. (HF + E.S.) for 10 weeks. Data are expressed as
mean ± SEM. “*” indicates significant difference vs Std group
(**p < .01; ***p < .001) while “§” indicates significant difference vs HF
group (§§p < .01). Number of animals for each group is n = 10
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from us, strengths this paradigm. Moreover, a well-recognized early
marker of alteration of adipose tissue metabolism is the CS, a mito-
chondrial enzyme that acts as a rate-limiting enzyme in the first step
of the Krebs cycle. It is largely used for evaluating mitochondrial oxi-
dative capacity and its activity results almost half following an HF-
feeding. Noteworthy, a compromised activity of CS is evident even
before that ultra-structural alterations or mitochondrial dysfunctions
appear (Cummins et al., 2014). In these experimental conditions, the
supplementation with E.S. seed extract contributed to enhance CS
activity in WAT, demonstrating an improvement of the metabolism of
adipocytes.
These results are in accordance with the literature published on
other Brassicaceae vegetables; indeed, many preclinical and clinical
reports demonstrated their antioxidant activity (Bahadoran
et al., 2011), anti-obesity and hypo-lipidemic effects in rats fed with
HF diet (Lee, Kim, & Lee, 2018). For instance, 4-week supplementa-
tion with Brassica rapa L. (var. perviridis) juice contributed to reduce
cholesterol levels in middle-aged men, through an improvement of
cholesterol metabolism (Aiso, Inoue, Seiyama, & Kuwano, 2014).
Another study reported the hypo-lipidemic effects of broccoli; in par-
ticular, 400 g of broccoli, containing high amount of glucoraphanin,
improved fatty acid oxidation and tricarboxylic acid cycle activity
within mitochondria, probably due to Nrf2-mediated modulation of
cellular redox status (Armah et al., 2013; Armah et al., 2015). Recently,
Lee et al. reported that supplementation with a Brassica juncea leaf
extract exerted positive effects on lipid profile and on body fat in rats
fed with HF diet. Indeed, a reduction of body fat accumulation and an
improvement of lipid profile, by modulating lipogenesis and choles-
terol metabolism, have been described (Lee et al., 2018). Similar
results have been obtained with a supplementation of red cabbage
(Brassica oleracea L. var. capitate) in rats fed with a HF diet. Huang
and colleagues highlighted its hypocholesterolemic effects without
showing significant impact on body weight; moreover, reduction of
pro-inflammatory cytokines and increase of ACAT1 expression, which
is involved in the fatty acid oxidation, have been found (Huang
et al., 2016).
Recently, it has been also suggested that many Brassicaceae
plants exert promising hypoglycemic effects. For example, B. oleracea
L. leaves produced, in streptozocin-induced diabetic rats, marked
reduction in both blood glucose and HbA1c levels, and a marked
increase in insulinemia (Shah, Shaker, & Gousuddin, 2016). In addition,
Akbari and colleagues have recently described the hypoglycemic prop-
erties of Brassica napus L. on diabetic rats (Akbari et al., 2016). Finally,
the consumption of Brassicaceae vegetables has been associated with
significant decrease of serum insulin concentration in type II diabetes
patients (Bahadoran et al., 2012; Yokozawa, Kim, Cho, Yamabi, &
Choi, 2003; Yun et al., 2018).
In our experimental conditions, although there was not a hyper-
glycemic condition, higher HbA1c levels have been measured in blood
of mice fed with a HF diet, suggesting an early alteration of glucose
homeostasis, which is prodromal to type II diabetes (Qaseem
et al., 2018). Interestingly, E.S. markedly reduced both blood glucose
and HbA1c levels in mice fed with a HF diet, indicating that
E.S. extract represents a promising nutraceutical approach to improve
the glucose metabolism. In the light of these results, it is possible to
hypothesize that E.S. extract can positively influence the metabolism
of glucose, although further evaluations are still needed.
Notable, key bioactive components in Brassicaceae vegetables
are glucosinolates and their derivatives isothiocyanates, which are
produced by the myrosinase enzyme (Palliyaguru et al., 2018). Very
recently, the well-known glucosinolate glucoraphanin, similarly to
crude Brassica extracts, ameliorated inflammation and reduced insu-
lin resistance associated with obesity. Nrf2 has been recognized as a
main player in these beneficial effects, since the activation of Nrf2
promotes the stimulation of both AMPK and uncoupling protein
UCP1, which are involved in the energy consumption (Xu, Nagata, &
F IGURE 3 Effects of Eruca sativa Mill. seed extract on adipose tissue. Graphs represent the weight of WAT (a) and the activity of CS (b) in
the adipose tissue of mice fed with Std diet, standard diet plus Eruca sativa Mill. (Std + E.S.), HF or HF diet plus Eruca sativa Mill. (HF + E.S.) for
10 weeks. Data are expressed as mean ± SEM. “*” indicates significant difference vs Std group (*p < .05) while “§” indicates significant difference
vs HF group (§p < .05). Number of animals for each group is n = 10
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Ota, 2018). Interestingly, natural isothiocyanates have been
described as H2S-releasing moieties and H2S has been proposed to
be the likely player of many biological and pharmacological effects
of isothiocyanates and of Brassicaceae plants/extracts (Citi
et al., 2014; Martelli et al., 2020a). As above reported, H2S-releasing
properties of erucin have been recently demonstrated (Martelli
et al., 2020b).
H2S has recently gained significant attention as biological media-
tor implicated in several pathological conditions, including obesity.
Indeed, it is produced in adipose tissue and is involved in
adipogenesis, metabolism and adipokine production (Bełtowski &
Jamroz-Wisniewska, 2016). Reduced levels of H2S-synthesizing
enzymes have been reported in fat tissues of obese mice, as well as in
db/db animals (Katsouda, Szabo, & Papapetropoulos, 2018).
F IGURE 4 Histological evaluation of adipocyte size. Photomicrographs of hematoxylin and eosin (H&E) stained adipose tissue sections from:
(a) mice fed with a Std diet; (b) mice fed with a HF diet; (c) mice fed with a HF diet plus Eruca sativa Mill. (HF + E.S.) for 10 weeks. Scale bar is
equal to 10 μm. Histograms (d) represent the mean size of adypocites from each experimental group. Data are expressed as mean ± SEM. “*”
indicates significant difference vs Std group (***p < 0.001) while “§” indicates significant difference vs HF group (§p < 0.05). Number of animals for
each group is n = 5 [Colour figure can be viewed at wileyonlinelibrary.com]
TABLE 2 Measurement of
cardiometabolic parameters
Std Std + E.S. HF HF + E.S.
Total cholesterol (mg dl−1) 148.0 ± 12.0 177.0 ± 17.1 247.2 ± 15.1** 221.8 ± 7.4*
LDL (mg dl−1) 80.3 ± 9.5 75.6 ± 7.4 114.8 ± 7.2** 104.0 ± 6.6*
Triglycerides (mg dl−1) 119.5 ± 8.4 84.8 ± 10.4* 150 ± 20.5 103.2 ± 3.8§
Note: Table shows the total cholesterol, LDL and triglycerides levels measured in mice fed with standard
diet (Std group), standard diet plus Eruca sativa Mill. seed extract (Std + E.S.), high-fat diet (HF group) and
HF diet plus Eruca sativa Mill. seed extract (HF + E.S. group). The values are expressed as mean ± SEM.
“*” indicates significant difference vs Std group (**p < .01) while “§” indicates significant difference vs HF
group (§p < .05).
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At this regard, down-regulation of endogenous H2S production
and alteration of glucose metabolism were also observed in HF diet-
treated mice, suggesting that H2S deficiency promoted a reduction in
levels of the myokine recently described irisin and subsequent meta-
bolic imbalance. Interestingly, treatment with exogenous sources of
H2S led to beneficial effects on muscle glucose homeostasis via the
irisin pathway (Parsanathan & Jain, 2018).
Therefore, it can be hypothesized that H2S, released from sulfur
secondary metabolites (namely glucoerucin and erucin) may be a rele-
vant player in the metabolic beneficial effects of E.S. seed extract
observed in this experimental work. Future studies will be specifically
focused on the exploration of the mechanisms of action, with particu-
lar attention on the potential role of H2S.
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